Axogen, Inc. Common Stock

AXGN Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership

Chart provided by TradingView

Income
Balance Sheet
Cash Flow
AXGN Income Statement
AXGN Balance Sheet
AXGN Cash Flow
Congress Trading

Recent trades of AXGN by members of U.S. Congress

Politician Type Traded
Donna E. Shalala House / D Sale $1,001 - $15,000 Jun. 24, 2019
Donna E. Shalala House / D Purchase $1,001 - $15,000 Apr. 16, 2019
AXGN Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
AXGN Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
AXGN Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by AXGN's directors and management

Corporate Lobbying

Government lobbying spending instances

  • $10,000 Nov 06, 2024 Issue: Health Issues
  • $10,000 Aug 08, 2024 Issue: Health Issues
  • $10,000 May 06, 2024 Issue: Health Issues
  • $10,000 Feb 05, 2024 Issue: Health Issues
  • $10,000 Nov 14, 2023 Issue: Health Issues
  • $10,000 Aug 07, 2023 Issue: Health Issues
  • $10,000 May 07, 2023 Issue: Health Issues
  • $10,000 Feb 09, 2023 Issue: Health Issues
  • $10,000 Nov 06, 2022 Issue: Health Issues
  • $10,000 Jul 18, 2022 Issue: Health Issues
  • $10,000 May 25, 2022 Issue: Health Issues
  • $30,000 Jan 19, 2011 Issue: Medical/Disease Research/Clinical Labs
  • $36,000 Oct 16, 2010 Issue: Medical/Disease Research/Clinical Labs
  • $36,000 Jul 14, 2010 Issue: Medical/Disease Research/Clinical Labs
  • $12,000 Apr 18, 2010 Issue: Medical/Disease Research/Clinical Labs
Corporate Lobbying

Estimated quarterly lobbying spending

U.S. Patents

New patents grants

  • Patent Title: Wet preservation of tissue Dec. 03, 2024
  • Patent Title: Fasciculated nerve grafts, methods of making the same, and methods of treatment using the same Jun. 04, 2024
  • Patent Title: Tissue grafts with pre-made attachment points May. 14, 2024
  • Patent Title: Organotypic drg-peripheral nerve culture system Apr. 16, 2024
  • Patent Title: Tissue-processing container for automated processing of tissue, methods of use thereof, and systems comprising the same Mar. 19, 2024
  • Patent Title: Organotypic drg-peripheral nerve culture system Jan. 30, 2024
  • Patent Title: Quantitative structural assay of a nerve graft Dec. 19, 2023
  • Patent Title: Wet preservation of tissue Aug. 29, 2023
  • Patent Title: Implant devices with a pre-set pulley system Feb. 28, 2023
  • Patent Title: Amnion tissue grafts and methods of preparing and using same Feb. 14, 2023
  • Patent Title: Wet preservation of tissue Dec. 13, 2022
  • Patent Title: Nerve culture system Nov. 29, 2022
  • Patent Title: Capture-tool for manipulating and entubulating nerves Jul. 12, 2022
  • Patent Title: Tissue grafts with pre-made attachment points Nov. 09, 2021
  • Patent Title: Organotypic drg-peripheral nerve culture system Oct. 26, 2021
  • Patent Title: Devices and methods for protecting against neuromas Oct. 19, 2021
  • Patent Title: Materials and methods for nerve repair with animal-sourced grafts Oct. 19, 2021
  • Patent Title: Materials and methods for protecting against neuromas Mar. 23, 2021
  • Patent Title: Materials and methods for protecting against neuromas Mar. 16, 2021
  • Patent Title: Implant devices with a pre-set pulley system Mar. 16, 2021
  • Patent Title: Connector and wrap for end-to-side nerve coaptation Nov. 17, 2020
  • Patent Title: Materials and methods for breast neurotization with nerve grafts Oct. 27, 2020
  • Patent Title: Quantitative structural assay of a nerve graft Sep. 22, 2020
  • Patent Title: Surgical tool for tissue sizing and transection Oct. 15, 2019
  • Patent Title: Capture-tool for manipulating and entubulating nerves Jul. 09, 2019
  • Patent Title: Quantitative structural assay of a nerve graft Jun. 04, 2019
  • Patent Title: Quantitative structural assay of a nerve graft Jun. 12, 2018
  • Patent Title: Quantitative structural assay of a nerve graft Jun. 27, 2017
  • Patent Title: Materials and methods for protecting against neuromas Apr. 25, 2017
  • Patent Title: Two-point discriminator sensory measurement device Jan. 31, 2017
  • Patent Title: Nerve elevator and method of use Oct. 01, 2013
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of AXGN in WallStreetBets Daily Discussion

AXGN News

Recent insights relating to AXGN

CNBC Recommendations

Recent picks made for AXGN stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in AXGN

AXGN Top Shareholders
Shareholder
Shares Held
AXGN Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

AXGN Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view AXGN Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top